Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor B Resnick

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2009
Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD)Sharon Elad, Itai Zeevi, Reuven Or, et al.
Annals of Medicine|September 14, 2007
Hematopoietic stem cell therapy for malignant diseasesMichael Y Shapira, Ali Abdul Hai, Panagiotis Tsirigotis, et al.
Pediatric Blood & Cancer|November 6, 2009
Isolated CNS vasculitis: unusual presentation of relapsed Ewing sarcomaPolina Stepensky, Elisha Waldman, Natalia Simanovsky, et al.
Transplant Immunology|March 3, 2007
N-acetylcysteine mildly inhibits the graft-vs.-leukemia effect but not the lymphokine activated cells (LAK) activityLola Weiss, Shoshana Reich, Michael Zeira, et al.
Annals of Hematology|August 21, 2009
Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphomaPanagiotis Tsirigotis, Liliane Dray, Igor B Resnick, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 15, 2012
The effect of cyclosporine initiation time on the outcome of matched allogeneic stem-cell transplantation following fludarabine-based conditioningMeirav Kedmi, Lilane Dray, Sigal Grisariu, et al.
Pediatric Blood & Cancer|May 28, 2011
Congenital cytomegalovirus infection and Wiskott-Aldrich syndrome successfully treated with unrelated cord blood transplantationYotam Almagor, Shoshana Revel-Vilk, Diana Averbuch, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine modelMichael Y Shapira, Ester Hirshfeld, Lola Weiss, et al.
The Journal of Infectious Diseases|August 29, 2013
High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantationEinat Shmueli, Reuven Or, Michael Y Shapira, et al.
American Journal of Hematology|December 24, 2008
Successful cell-mediated cytokine-activated immunotherapy for relapsed acute myeloid leukemia after hematopoietic stem cell transplantationBenjamin Gesundheit, Michael Y Shapira, Igor B Resnick, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2009
Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD)Sharon Elad, Itai Zeevi, Reuven Or, et al.
Annals of Medicine|September 14, 2007
Hematopoietic stem cell therapy for malignant diseasesMichael Y Shapira, Ali Abdul Hai, Panagiotis Tsirigotis, et al.
Pediatric Blood & Cancer|November 6, 2009
Isolated CNS vasculitis: unusual presentation of relapsed Ewing sarcomaPolina Stepensky, Elisha Waldman, Natalia Simanovsky, et al.
Transplant Immunology|March 3, 2007
N-acetylcysteine mildly inhibits the graft-vs.-leukemia effect but not the lymphokine activated cells (LAK) activityLola Weiss, Shoshana Reich, Michael Zeira, et al.
Annals of Hematology|August 21, 2009
Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphomaPanagiotis Tsirigotis, Liliane Dray, Igor B Resnick, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 15, 2012
The effect of cyclosporine initiation time on the outcome of matched allogeneic stem-cell transplantation following fludarabine-based conditioningMeirav Kedmi, Lilane Dray, Sigal Grisariu, et al.
Pediatric Blood & Cancer|May 28, 2011
Congenital cytomegalovirus infection and Wiskott-Aldrich syndrome successfully treated with unrelated cord blood transplantationYotam Almagor, Shoshana Revel-Vilk, Diana Averbuch, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine modelMichael Y Shapira, Ester Hirshfeld, Lola Weiss, et al.
The Journal of Infectious Diseases|August 29, 2013
High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantationEinat Shmueli, Reuven Or, Michael Y Shapira, et al.
American Journal of Hematology|December 24, 2008
Successful cell-mediated cytokine-activated immunotherapy for relapsed acute myeloid leukemia after hematopoietic stem cell transplantationBenjamin Gesundheit, Michael Y Shapira, Igor B Resnick, et al.
Pageof 5